Literature DB >> 19811809

Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance.

Paulette Mhawech-Fauceglia1, Francois R Herrmann, Heidi Wagner, Heidi Godoy, Kunle Odunsi, Richard T Cheney, Shashikant Lele.   

Abstract

BACKGROUND AND AIMS: Lymph node (LN) status in gynecologic malignancies plays an important role in patient staging, management, and prognosis. Therefore, an adequacy of LN harvest is crucial. The aim of this study is to determine whether the submission of the entire LN dissection for histologic examination will affect patients' outcome or clinical stage. We also evaluated the time required and cost-effectiveness for the laboratory.
MATERIALS AND METHODS: A prospective study of 134 surgical cases from various gynecologic malignancies was conducted. The LN dissection specimen was performed using a conventional manual node dissection method with all the remaining fat being submitted in additional cassettes. One pathologist evaluated (1) the number and status of palpable LNs identified by the conventional method as well as the number of tissue cassettes and (2) the number, size, and status of the non-palpable LNs as well as the number of tissue cassettes.
RESULTS: The palpable LNs ranged from 0 to 36 with average 14.8 LNs per case (Poisson 95% CI: 14.1-15.4). The additional non-palpable LNs ranged from 0 to 16 with an average of 3.1 (Poisson 95% CI: 2.8-3.4). In only one case, a 3-mm non-palpable LN with metastasis was identified; however, it did not affect tumor staging or patient management.
CONCLUSION: The impact on patient outcome is minimal and it does not prove to be cost and time effective when submitting the entire LN dissection specimen in gynecologic malignancies. However, this method could be justified in selective cases in which the manual node dissection does not reveal an adequate number of LNs.

Entities:  

Mesh:

Year:  2009        PMID: 19811809      PMCID: PMC5047373          DOI: 10.1016/j.ygyno.2009.09.008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  Efficacy of manual dissection of lymph nodes in colon cancer resections.

Authors:  Henry G Brown; Todd M Luckasevic; David S Medich; James P Celebrezze; Sandra M Jones
Journal:  Mod Pathol       Date:  2004-04       Impact factor: 7.842

2.  The prognostic significance of surgical staging for carcinoma of the endometrium.

Authors:  A H Wolfson; S E Sightler; A M Markoe; J G Schwade; H E Averette; P Ganjei; S G Hilsenbeck
Journal:  Gynecol Oncol       Date:  1992-05       Impact factor: 5.482

3.  A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma.

Authors:  K Hirahatake; H Hareyama; N Sakuragi; M Nishiya; S Makinoda; S Fujimoto
Journal:  J Surg Oncol       Date:  1997-06       Impact factor: 3.454

Review 4.  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

Authors:  A Goldhirsch; J H Glick; R D Gelber; H J Senn
Journal:  J Natl Cancer Inst       Date:  1998-11-04       Impact factor: 13.506

5.  The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer.

Authors:  H Kotanagi; T Fukuoka; Y Shibata; T Yoshioka; O Aizawa; Y Saito; G E Tur; K Koyama
Journal:  J Surg Oncol       Date:  1993-12       Impact factor: 3.454

Review 6.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 7.  College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants.

Authors:  M E Hammond; P L Fitzgibbons; C C Compton; D J Grignon; D L Page; L P Fielding; D Bostwick; T F Pajak
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

8.  Additional lymph node examination from entire submission of residual mesenteric tissue in colorectal cancer specimens may not add clinical and pathologic relevance.

Authors:  Young Min Kim; Jae Hee Suh; Hee Jeong Cha; Se J Jang; Mi-Jung Kim; Sunoch Yoon; Baekhui Kim; Heejin Chang; Youngmee Kwon; Eun Kyung Hong; Jae Y Ro
Journal:  Hum Pathol       Date:  2007-02-15       Impact factor: 3.466

9.  FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.

Authors:  R E Bristow; M L Zahurak; C J Alexander; R C Zellars; F J Montz
Journal:  Int J Gynecol Cancer       Date:  2003 Sep-Oct       Impact factor: 3.437

10.  Clearance technique for the detection of lymph nodes in colorectal cancer.

Authors:  S J Cawthorn; N M Gibbs; C G Marks
Journal:  Br J Surg       Date:  1986-01       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.